Global Pneumococcal Vaccine Market Size, Share, Growth Analysis Report - Forecast 2034
Pneumococcal Vaccine Market By Vaccine Type (Conjugate Vaccines, Polysaccharide Vaccines), By Dosage (Single Dose, Multiple Dose), By Age Group (Pediatrics, Adults, Geriatrics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Government Supply Programs, Online Pharmacies), By End-user (Hospitals, Clinics, Government Organizations), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 219 Report Code: ZMR-7596
Published Date: Jun-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 8.15 Billion | USD 15.59 Billion | 6.2% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Pneumococcal Vaccine Market, (2023 - 2030) (USD Billion)
- 2.2 Global Pneumococcal Vaccine Market : snapshot
- Chapter 3. Global Pneumococcal Vaccine Market - Industry Analysis
- 3.1 Pneumococcal Vaccine Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 The high burden of disease drives market expansion
- 3.3 Market Restraints
- 3.3.1. Issues related to the supply chain hamper the market growth
- 3.4 Market Opportunities
- 3.4.1. Growing awareness provides an attractive opportunity for market growth
- 3.5 Market Challenges
- 3.5.1. Emerging antibiotic resistance poses a challenge to market growth
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Vaccine Type
- 3.7.2 Market attractiveness analysis By Product Type
- 3.7.3 Market attractiveness analysis By Distribution Channel
- Chapter 4. Global Pneumococcal Vaccine Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Pneumococcal Vaccine Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Pneumococcal Vaccine Market - Vaccine Type Analysis
- 5.1 Global Pneumococcal Vaccine Market overview: By Vaccine Type
- 5.1.1 Global Pneumococcal Vaccine Market share, By Vaccine Type, 2022 and 2030
- 5.2 Pneumococcal Conjugate Vaccine
- 5.2.1 Global Pneumococcal Vaccine Market by Pneumococcal Conjugate Vaccine, 2023 - 2030 (USD Billion)
- 5.3 Pneumococcal Polysaccharide Vaccine
- 5.3.1 Global Pneumococcal Vaccine Market by Pneumococcal Polysaccharide Vaccine, 2023 - 2030 (USD Billion)
- 5.1 Global Pneumococcal Vaccine Market overview: By Vaccine Type
- Chapter 6. Global Pneumococcal Vaccine Market - Product Type Analysis
- 6.1 Global Pneumococcal Vaccine Market overview: By Product Type
- 6.1.1 Global Pneumococcal Vaccine Market share, By Product Type, 2022 and 2030
- 6.2 Prevnar 13
- 6.2.1 Global Pneumococcal Vaccine Market by Prevnar 13, 2023 - 2030 (USD Billion)
- 6.3 Synflorix
- 6.3.1 Global Pneumococcal Vaccine Market by Synflorix, 2023 - 2030 (USD Billion)
- 6.4 Pneumovax 23
- 6.4.1 Global Pneumococcal Vaccine Market by Pneumovax 23, 2023 - 2030 (USD Billion)
- 6.1 Global Pneumococcal Vaccine Market overview: By Product Type
- Chapter 7. Global Pneumococcal Vaccine Market - Distribution Channel Analysis
- 7.1 Global Pneumococcal Vaccine Market overview: By Distribution Channel
- 7.1.1 Global Pneumococcal Vaccine Market share, By Distribution Channel, 2022 and 2030
- 7.2 Distribution Partner Companies
- 7.2.1 Global Pneumococcal Vaccine Market by Distribution Partner Companies, 2023 - 2030 (USD Billion)
- 7.3 Non-governmental Organizations (NGO)
- 7.3.1 Global Pneumococcal Vaccine Market by Non-governmental Organizations (NGO), 2023 - 2030 (USD Billion)
- 7.4 Government Authorities
- 7.4.1 Global Pneumococcal Vaccine Market by Government Authorities, 2023 - 2030 (USD Billion)
- 7.1 Global Pneumococcal Vaccine Market overview: By Distribution Channel
- Chapter 8. Pneumococcal Vaccine Market - Regional Analysis
- 8.1 Global Pneumococcal Vaccine Market Regional Overview
- 8.2 Global Pneumococcal Vaccine Market Share, by Region, 2022 & 2030 (USD Billion)
- 8.3. North America
- 8.3.1 North America Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 8.3.1.1 North America Pneumococcal Vaccine Market, by Country, 2023 - 2030 (USD Billion)
- 8.3.1 North America Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 8.4 North America Pneumococcal Vaccine Market, by Vaccine Type, 2023 - 2030
- 8.4.1 North America Pneumococcal Vaccine Market, by Vaccine Type, 2023 - 2030 (USD Billion)
- 8.5 North America Pneumococcal Vaccine Market, by Product Type, 2023 - 2030
- 8.5.1 North America Pneumococcal Vaccine Market, by Product Type, 2023 - 2030 (USD Billion)
- 8.6 North America Pneumococcal Vaccine Market, by Distribution Channel, 2023 - 2030
- 8.6.1 North America Pneumococcal Vaccine Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- 8.4. Europe
- 8.4.2 Europe Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 8.4.2.1 Europe Pneumococcal Vaccine Market, by Country, 2023 - 2030 (USD Billion)
- 8.4.2 Europe Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 8.4 Europe Pneumococcal Vaccine Market, by Vaccine Type, 2023 - 2030
- 8.4.1 Europe Pneumococcal Vaccine Market, by Vaccine Type, 2023 - 2030 (USD Billion)
- 8.5 Europe Pneumococcal Vaccine Market, by Product Type, 2023 - 2030
- 8.5.1 Europe Pneumococcal Vaccine Market, by Product Type, 2023 - 2030 (USD Billion)
- 8.6 Europe Pneumococcal Vaccine Market, by Distribution Channel, 2023 - 2030
- 8.6.1 Europe Pneumococcal Vaccine Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 8.5.3.1 Asia Pacific Pneumococcal Vaccine Market, by Country, 2023 - 2030 (USD Billion)
- 8.5.3 Asia Pacific Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 8.4 Asia Pacific Pneumococcal Vaccine Market, by Vaccine Type, 2023 - 2030
- 8.4.1 Asia Pacific Pneumococcal Vaccine Market, by Vaccine Type, 2023 - 2030 (USD Billion)
- 8.5 Asia Pacific Pneumococcal Vaccine Market, by Product Type, 2023 - 2030
- 8.5.1 Asia Pacific Pneumococcal Vaccine Market, by Product Type, 2023 - 2030 (USD Billion)
- 8.6 Asia Pacific Pneumococcal Vaccine Market, by Distribution Channel, 2023 - 2030
- 8.6.1 Asia Pacific Pneumococcal Vaccine Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- 8.6. Latin America
- 8.6.4 Latin America Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 8.6.4.1 Latin America Pneumococcal Vaccine Market, by Country, 2023 - 2030 (USD Billion)
- 8.6.4 Latin America Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 8.4 Latin America Pneumococcal Vaccine Market, by Vaccine Type, 2023 - 2030
- 8.4.1 Latin America Pneumococcal Vaccine Market, by Vaccine Type, 2023 - 2030 (USD Billion)
- 8.5 Latin America Pneumococcal Vaccine Market, by Product Type, 2023 - 2030
- 8.5.1 Latin America Pneumococcal Vaccine Market, by Product Type, 2023 - 2030 (USD Billion)
- 8.6 Latin America Pneumococcal Vaccine Market, by Distribution Channel, 2023 - 2030
- 8.6.1 Latin America Pneumococcal Vaccine Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 8.7.5.1 The Middle-East and Africa Pneumococcal Vaccine Market, by Country, 2023 - 2030 (USD Billion)
- 8.7.5 The Middle-East and Africa Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 8.4 The Middle-East and Africa Pneumococcal Vaccine Market, by Vaccine Type, 2023 - 2030
- 8.4.1 The Middle-East and Africa Pneumococcal Vaccine Market, by Vaccine Type, 2023 - 2030 (USD Billion)
- 8.5 The Middle-East and Africa Pneumococcal Vaccine Market, by Product Type, 2023 - 2030
- 8.5.1 The Middle-East and Africa Pneumococcal Vaccine Market, by Product Type, 2023 - 2030 (USD Billion)
- 8.6 The Middle-East and Africa Pneumococcal Vaccine Market, by Distribution Channel, 2023 - 2030
- 8.6.1 The Middle-East and Africa Pneumococcal Vaccine Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Walvax Biotechnology Co. Ltd.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Sk Bioscience
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Panacea Biotec Limited
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Shenzhen Kangtai Biological Products Co. Ltd.
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 (Beijing Minhai Biotechnology Corporation Limited)
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Serum Institute of India Pvt. Ltd.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Merck & Co. Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Pfizer Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Lg Chem Ltd.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Pnuvax Incorporated
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Glaxosmithkline Plc.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 and others.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.1 Walvax Biotechnology Co. Ltd.
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Pneumococcal Vaccine Market attractiveness, By Vaccine Type
- 6. Global Pneumococcal Vaccine Market attractiveness, By Product Type
- 7. Global Pneumococcal Vaccine Market attractiveness, By Distribution Channel
- 8. Global Pneumococcal Vaccine Market share by Vaccine Type, 2023 and 2030 (USD Billion)
- 9. Global Pneumococcal Vaccine Market by Pneumococcal Conjugate Vaccine, 2023 - 2030 (USD Billion)
- 10. Global Pneumococcal Vaccine Market by Pneumococcal Polysaccharide Vaccine, 2023 - 2030 (USD Billion)
- 11. Global Pneumococcal Vaccine Market share by Product Type, 2023 and 2030 (USD Billion)
- 12. Global Pneumococcal Vaccine Market by Prevnar 13, 2023 - 2030 (USD Billion)
- 13. Global Pneumococcal Vaccine Market by Synflorix, 2023 - 2030 (USD Billion)
- 14. Global Pneumococcal Vaccine Market by Pneumovax 23, 2023 - 2030 (USD Billion)
- 15. Global Pneumococcal Vaccine Market share by Distribution Channel, 2023 and 2030 (USD Billion)
- 16. Global Pneumococcal Vaccine Market by Distribution Partner Companies, 2023 - 2030 (USD Billion)
- 17. Global Pneumococcal Vaccine Market by Non-governmental Organizations (NGO), 2023 - 2030 (USD Billion)
- 18. Global Pneumococcal Vaccine Market by Government Authorities, 2023 - 2030 (USD Billion)
- 19. Global Pneumococcal Vaccine Market share, by Region, 2023 and 2030
- 20. North America Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 21. Europe Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 22. Asia Pacific Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 23. Latin America Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
- 24. The Middle-East and Africa Pneumococcal Vaccine Market, 2023 - 2030 (USD Billion)
Table Of Tables
- 1. Global Pneumococcal Vaccine Market: Snapshot
- 2. Drivers of the Pneumococcal Vaccine Market: impact analysis
- 3. North America Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 4. North America Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 5. North America Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 6. U.S. Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 7. U.S. Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 8. U.S. Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 9. Canada Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 10. Canada Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 11. Canada Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 12. Europe Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 13. Europe Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 14. Europe Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 15. Germany Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 16. Germany Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 17. Germany Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 18. France Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 19. France Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 20. France Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 21. U.K. Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 22. U.K. Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 23. U.K. Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 24. Italy Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 25. Italy Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 26. Italy Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 27. Spain Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 28. Spain Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 29. Spain Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 30. Rest of Europe Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 31. Rest of Europe Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 32. Rest of Europe Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 33. Asia Pacific Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 34. Asia Pacific Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 35. Asia Pacific Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 36. China Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 37. China Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 38. China Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 39. Japan Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 40. Japan Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 41. Japan Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 42. India Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 43. India Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 44. India Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 45. South Korea Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 46. South Korea Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 47. South Korea Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 48. South-East Asia Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 49. South-East Asia Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 50. South-East Asia Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 51. Rest of Asia Pacific Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 52. Rest of Asia Pacific Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 53. Rest of Asia Pacific Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 54. Latin America Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 55. Latin America Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 56. Latin America Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 57. Brazil Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 58. Brazil Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 59. Brazil Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 60. Mexico Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 61. Mexico Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 62. Mexico Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 63. Rest of Latin America Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 64. Rest of Latin America Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 65. Rest of Latin America Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 66. The Middle-East and Africa Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 67. The Middle-East and Africa Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 68. The Middle-East and Africa Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 69. GCC Countries Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 70. GCC Countries Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 71. GCC Countries Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 72. South Africa Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 73. South Africa Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 74. South Africa Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 75. Rest of Middle-East Africa Pneumococcal Vaccine Market revenue, By Vaccine Type, 2023 - 2030 (USD Billion)
- 76. Rest of Middle-East Africa Pneumococcal Vaccine Market revenue, By Product Type, 2023 - 2030 (USD Billion)
- 77. Rest of Middle-East Africa Pneumococcal Vaccine Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
Methodology
FrequentlyAsked Questions
Pneumococcal vaccinations are those that shield people from pneumococcal diseases. The bacterium Streptococcus pneumonia is responsible for the disease. Vaccines against pneumococci can shield people against diseases including sepsis, meningitis, and pneumonia. Vaccines may be divided into two categories: polysaccharide vaccines and conjugate vaccinations. The drug is administered by injecting it either into the muscle or just beneath the skin. Children and newborns should get conjugate vaccinations as part of a standard immunization schedule, according to the World Health Organization (WHO).
The global pneumococcal vaccine market is expected to grow due to rising awareness of pneumococcal diseases, government immunization programs, and growing geriatric and pediatric populations.
According to a study, the global pneumococcal vaccine market size was worth around USD 8.15 Billion in 2024 and is expected to reach USD 15.59 Billion by 2034.
The global pneumococcal vaccine market is expected to grow at a CAGR of 6.2% during the forecast period.
North America is expected to dominate the pneumococcal vaccine market over the forecast period.
Leading players in the global pneumococcal vaccine market include Walvax Biotechnology Co. Ltd., Sk Bioscience, Panacea Biotec Limited, Shenzhen Kangtai Biological Products Co. Ltd., (Beijing Minhai Biotechnology Corporation Limited), Serum Institute of India Pvt. Ltd., Merck & Co. Inc., Pfizer Inc., Lg Chem Ltd., Pnuvax Incorporated, Glaxosmithkline Plc., and others., among others.
The report explores crucial aspects of the pneumococcal vaccine market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed